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ABSTRACT  
Each and every biological function in living organism happens as a result of protein-protein interactions. 
The diseases are no exception to this. Identifying one or more proteins for a particular disease and then 
designing a suitable chemical compound (known as drug) to destroy these proteins has been an 
interesting topic of research in bio-informatics. In previous methods, drugs were designed using only 
seven chemical components and were represented as a fixed-length tree. But in reality, a drug contains 
many chemical groups collectively known as pharmacophore. Moreover, the chemical length of the drug 
cannot be determined before designing the drug. 
In the present work, a Particle Swarm Optimization (PSO) based methodology has been proposed to find 
out a suitable drug for a particular disease so that the drug-protein interaction becomes stable. In the 
proposed algorithm, the drug is represented as a variable length tree and essential functional groups are 
arranged in different positions of that drug. Finally, the structure of the drug is obtained and its docking 
energy is minimized simultaneously. Also, the orientation of chemical groups in the drug is tested so that 
it can bind to a particular active site of a target protein and the drug fits well inside the active site of 
target protein. Here, several inter-molecular forces have been considered for accuracy of the docking 
energy. Results show that PSO performs better than the earlier methods. 
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1. INTRODUCTION 
Protein is a macro molecule primarily consisting of amino acids [1]. Protein is highly 
responsible for structural and functional characteristics of cells, and communication of 
biological signals among cells. All proteins available in the nature are not useful for the living 
organism. However, every biological function in living organism happens as a result of protein-
protein interactions [2, 3]. There are evidences of proteins which cause fatal or infective 
diseases. Researchers take keen interest to identify appropriate drug that fits well in the active 
sites of harmful protein. These drugs, which can bind in the active site of target protein and 
therefore change the functional behavior of that particular protein, are called ligands. This 
mechanism of binding of drug with the target protein is called docking [4]. The challenge is to 
predict an accurate structure of the ligand when the active site configuration of the target protein 
is known. 
Docking is very much important in cellular biology. In docking, proteins interact with 
themselves and with other molecular components. It is the key concept to oriental drug design. 
The result of docking can be used to find inhibitors for specific target proteins and thus to 
design new stable drugs. Protein-ligand docking is an energy minimization search and 
optimization problem with the aim to find the best ligand conformation for active sites of a 
target protein.  
In this paper, the scope of the well-known Particle Swarm Optimization (PSO) algorithm [5, 2, 
6, 7] is studied to determine the ligand structure to be docked at the active site of the target 
protein. The choice of PSO in the present context is inspired by social behavior of bird flocking 
and fish schooling [8]. It begins with a random population and then searches for optimal 
solution by updating the population based on fitness of the current solution.  
Evolutionary computation is used to place functional groups in the nodes of the variable tree 
structured ligand. The tree structure helps in connecting primitive fragments or radicals to 
determine the right candidate solution for the ligand that best suits with the active site of the 
protein. The PSO based algorithm flows through the entire search space, and records the best 
individuals they have met. At each step, it changes its position according to the best individuals 
to reach a new position. In this way, the whole population evolves towards the optimum, step by 
step.  
A ‘fitness function’ is generally introduced in a meta-heuristics algorithm to determine the 
quality of the desired solutions for an optimization problem. Naturally, the better the 
formulation of the fitness function, the better is the expected quality of the trial solutions. In the 
present context of the ligand-docking problem, optimal selection of the ligand is inspired by 
minimization of an energy function that determines the stable connectivity between the protein 
and the ligand. So, the fitness function here is an energy function, whose minimization yields 
trial solutions to the problem. One important factor in the field of drug design is the 
identification of proper ligand. In general, one or more proteins are typically involved in the 
bio-chemical pathway of a disease. The treatment aims to appropriately identify those proteins 
and reduce their effects by designing a ligand molecule [9] that can bind to protein’s active site. 
That is, the structure of a ligand molecule is evolved from a set of groups in close proximity to 
crucial residues of the protein; a molecule is thereby designed that fits the protein target receptor 
such that a criterion for Van Der Waals & electrostatic interaction energy is optimized. We 
propose to adopt this approach in this paper. 
In this paper, we propose a novel approach by which the drug is represented by a variable length 
tree-like structure, forty-five functional groups, Van Der Waals as well as electrostatics force to 
design the ligand structure. We have applied our approach to Human Rhinovirus stain 14, 
Plasmodium Falciparum and HIV-1 protease viruses. We have significantly improved the work 
done by earlier researchers due to following reasons 1) A new representation for the ligand is 
used; 2) Both Van Der Waal and electrostatic energies are optimized and 3) PSO is used 
because of its ability to handle to the ligand design problem. It can be seen that PSO method has 
performed quite satisfactorily in comparison with Genetic Algorithm (GA) (fixed length tree) 
[10], Neighbourhood Based Genetic Algorithm (NBGA) (fixed length tree) [11], and variable 
length Neighbourhood Based Genetic Algorithm (VNBGA) (variable length tree) [12]. 
The rest of the paper is organized as follows. Section 2 briefs the related work. Section 3 
contains the formulation of protein–ligand docking problem; section 4 depicts the principles 
used to predict the ligand structures. In section 5, PSO algorithm used to find the best ligand 
structure is described. The pseudo-code for solving the given constrained optimization function 
is given in section 6. A comparison of experiment results for 3 proteins in section 7 is also 
given. Section 8 concludes the paper with the future work. 
2. RELATED WORK 
A fixed length Genetic Algorithm approach for ligand design was used in [10, 8, 13, 14] to 
evolve molecular structure of possible ligand that binds to a given target protein. The drug is 
represented by a fixed tree-like structure, comprising of molecules at the nodes and the bonds as 
links. Evidently, an a priori knowledge of the size and length of the tree is difficult to obtain 
before the experiment.  
Another approach for ligand design, which is based on variable length representation of trees on 
both sides of the pharmacophore was studied by Bandopadhyay et al [12]. However, the 
approach is restricted to build the ligand in two-dimensional space from a small suite of seven 
functional groups. Furthermore, the fitness value of the ligand is confined to Van Der Waals 
force only. 
One more approach for ligand design, that is based on the presence of a fixed pharmacophore 
and that uses the search capabilities of genetic algorithms, was studied by Goah and Foster [10], 
where the harmful protein human Rhinovirus strain14 was used as the target. This pioneering 
work assumed a fixed tree structure representation of the molecule on both sides of the 
pharmacophore. Evidently, an a priori knowledge of the size of the tree is difficult to obtain. 
Moreover, it is known that no unique ligand structure is best for a given active site geometry. 
Furthermore, few more algorithms were designed by researchers for ligand design viz. 
AutoDock 3.05, SODOCK and PSO@AUTODOCK. In [6], a novel optimization algorithm 
SODOCK is used for solving protein–ligand docking problems. And results are compared with 
the performance of AutoDock 3.05 [15]. SODOCK is based on particle swarm optimization and 
a local search strategy. The work uses the environment and energy function of AutoDock 3.05. 
Results show that SODOCK performs better than AutoDock in terms of convergence 
performance, robustness, and obtained energy. 
In [16], a novel meta-heuristic algorithm called PSO@AUTODOCK based on varCPSO and 
varCPSO-ls is used to calculate the docking energy. varCPSO stands for velocity adaptive and 
regenerative CPSO. varCPSO-ls is varCPSO with local search technique to avoid convergence 
at local minima. In addition to that, comparison is done with other docking techniques as GOLD 
3.0, DOCK 6.0, FLEXX 2.2.0, AUTODOCK 3.05, and SODOCK. It has been shown that 
PSO@AUTODOCK gives highly efficient docking program in terms of speed and quality for 
flexible peptide–protein docking and virtual screening studies. 
In our paper, we propose a PSO based approach wherein a variable length tree-like structure, 
forty-five functional groups, Van Der Waals and electrostatics force is used to design the ligand 
structure. We have compared our PSO based approach with GA (fixed length tree), NBGA 
(fixed length tree) and VNBGA (variable length tree).  
3. FORMULATION OF THE PROBLEM 
In protein-ligand docking problem, the objective is to minimize the energy. Firstly, the internal 
energy of the ligand should be minimized for better stability of the ligand [17]. The inter-
molecular energy value, which is thereafter optimized, is the interaction energy between the 
ligand and the active site of the receptor protein. This energy calculation is based on the 
proximity of the different residues in the active site of the receptor protein to the closest 
functional groups in the ligand and their chemical properties. The inter-molecular interaction 
energy is computed in terms of the Van Der Waals energy and the electrostatic energy. 
It is noted that the distance between a residue of the target protein receptor and its closest 
functional group should be between 0.7
0
A  and 2.7
0
A . If the functional group and closest residue 
are of different polarity, then electrostatic force of attraction also acts between those molecules. 
The interaction energy of the ligand with the protein is the sum of Van Der Waals Force and 
electrostatic energy [4]. 
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Where qA  and  qB  are the charges of the two atoms is the separation, ε is the dielectric constant 
of the surrounding medium r is the distance between charges. 
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Where A and B are constants and r is distance between the molecules. Value of A and B depends on 
the atom pair. 
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4. FORMATION OF A LIGAND 
In the proposed work, we consider that the ligands are built using the fragments from the suite 
as mentioned in Figure 4. Proteins with known active site configuration are used for evolving 
ligand structures. The specific target is the known antiviral binding site of the Human 
Rhinovirus strain 14, Plasmodium Falciparum and HIV-1 Protease. The active site of Human 
Rhinovirus strain 14 is known as the VP1 barrel as it resembles with a barrel. The molecules 
which can easily be fit in the structure having minimum interaction energy will be the evolved 
drug (i.e. ligand). For simplification; a 2-dimensional structure is chosen. 
 
 
 
 
 
 
AB
BA
r
qq
04piε
Figure 1. Active site of Human Rhinovirus stain 14 
Figure 1 illustrates the active site of Human Rhinovirus strain 14, Figure 2 illustrates the active 
site of Plasmodium Falciparum and Figure 3 illustrates the active site of HIV-1 protease. For 
designing the ligand, the co-ordinates of the active site of the protein must be known.  
In the present context, we represent a ligand as a variable length tree structure. The length of the 
ligand will be determined according to the active site of the target protein as it cannot be 
determined before finding its structure; this can be seen in Figure 1, Figure 2 and Figure 3. We 
have considered the variable length tree having total 15 nodes. These nodes will be filled by at 
most 15 functional groups appropriately selected from the set of forty-five functional groups 
given in Figure 4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Active site of HIV-I protease 
 
Figure 2. Active site of Plasmodium Falciparum 
 
  
 
Figure 4. A set of forty five groups used to build ligands (45th group is the NULL group) 
 
5. PARTICLE SWARM OPTIMIZATION ALGORITHM 
PSO or Particle Swarm Optimization algorithm is an evolutionary computation technique that 
was developed by DT Eberhart and Dr. Kennedy [18]. This algorithm is inspired by social 
behavior of bird flocking and fish schooling. It also begins with a random population and 
searches for optima by updating the population. In PSO, the potential solutions, called particles, 
flow through the whole search space by following the current optimum particles. Each particle 
has a speed vector and position vector to represent a possible solution. 
PSO uses a simple rule. Before a change, each particle has three choices: (1) insists on oneself 
(2) moves towards the optimum it has met (3) moves towards the best the population has met. 
PSO reaches to a balanced position among these three choices. The algorithm is described as 
follows: 
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Where V is the velocity, P is the position, k is number of iterations, d is number of particles, i is 
number of particle dimensions, W is inertia factor. C1 and C2 are acceleration coefficients. R1 
and R2 are two other constants in the interval (0, 1). 
6. SOLVING THE CONSTRAINT OPTIMIZATION PROBLEM USING PSO 
Input: 
 
1. Coordinates of active site.  
 
2. Valency and length of 45 functional groups.  
 
Output: Desired ligand structure L for receptor target protein P. 
 
 
Begin 
Call PSO (active_site_P); 
End 
 
Procedure PSO (active_site_P) 
Begin 
1. Initialize each particle Xi with 15 functional groups randomly chosen from the set of 
45 groups at Figure 4.   
2. Assign initial coordinates to each particle and call calculate energy (Xi ) to find 
respective fitness. 
3. Calculate fitness of each particle. 
4. Calculate velocity and position of PSO parameters. 
5. Update pBest and gBest as necessary. 
6. Repeat steps 2 to 5 until a convergence criterion is satisfies or maximum iteration 
ends.  
End 
7. EXPERIMENTS AND RESULTS 
The experiment was carried out in a simulated environment using MATLAB 2011. Population 
size for PSO is taken as 50 and the algorithm is run for 100 generation. In each generation, each 
of the particles is decoded to obtain the corresponding drug structure. Results are taken for 
different possible positions of the drug within the active site, and the evolved drug having the 
lowest energy value is taken as the solution. The two dimensional structure of the ligand is 
drawn using ChemSketch software [19]. 
We have applied our proposed PSO based approach on three different proteins viz. Rhino virus 
14 Mutant N1105S (1RUC), Plasmodium Falciparum (TS-DHFR) (3DGA) and HIV-1 Protease 
(1W5X). Information about these three proteins is obtained from Protein Data Bank 
(http://www.rcsb.org/pdb/home/home.do) and the active site of a protein is obtained from 
http://dogsite.zbh.uni-hamburg.de/ . Table 1 shows the diseases caused by each of these 
proteins. 
Table 1. Protein and corresponding disease caused by the protein.  
Name of the protein Disease caused by the protein 
Rhino virus 14 Mutant N1105S 
(1RUC) Cough and Cold 
Plasmodium Falciparum (TS-DHFR) 
(3DGA) Malaria 
HIV-1 Protease 
(1W5X) AIDS 
 
 
We have compared our PSO based approach using Van Der Waals force with other available 
approaches. The docking energy values of the ligand–protein complexes are calculated for 
Human Rhinovirus and are given in Table 2. Lower inter-molecular energy values of the ligand 
imply better stability of the ligand. As seen in Table 2, our PSO based approach provides more 
stable ligands that are associated with lower energy values. Moreover, the length of the ligand is 
also checked with the size of active sites. The length of the ligand should always be less than the 
length of the active site. In our experiments, it was found that the length of the active site was 
8.76
0
A  for Human Rhinovirus 14 Mutant N1105S, while the length of the ligand found using 
PSO was 8.72
0
A which is less than the length of the active site. Hence, the ligand can fit quite 
well inside corresponding active site.  
 
 
Table 2. Comparison of Result for Human Rhinovirus 
Serial 
Number Algorithm 
Docking Energy 
(Kcal/mol) 
1. Fixed length GA 
 
11.6454 
2. NBGA (fixed length) 
 
11.5748 
3. VNBGA  (Variable length) 
 
8.1046 
4. Our Proposed Method (Variable length 
PSO) 6.5385 
 
 
Figure 5. Comparison among algorithms mentioned in Table 2.  
We have applied Electrostatics force of attraction along with Van Der Waal force to the Human 
Rhinovirus; the results obtained are 10.6352 Kcal/mol. However, Van Der Waal force is applied 
to Plasmodium Falciparum and HIV-1 Protease and the results obtained are 2.5477 Kcal/mol 
and 13.4303 Kcal/mol respectively. The application of Electrostatics force along with Van Der 
Waals force for Plasmodium Falciparum and HIV-1 Protease will be kept for future work. 
The two dimensional structure of ligand molecule evolved using PSO are pictorially represented 
in Figure 6, 7 & 8 for Human Rhinovirus strain 14, Plasmodium Falciparum and HIV-1 
Protease respectively. It is clear from the figures that the design molecules using PSO fill up the 
active sites quite well. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Generated Ligand Structure for Plasmodium Falciparum 
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Figure 6. Generated Ligand Structure for Human Rhino Virus 
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Figure 8. Generated Ligand Structure for HIV-I Protease 
8. CONCLUSION AND FUTURE WORK 
We can conclude that the proposed PSO based algorithm primarily optimizes protein-ligand 
inter-molecular docking energy. Our algorithm finds the ligand structure in such a way that each 
ligand can fit into corresponding active site very well. It also gives better result (less energy) 
than other methods. Moreover, using PSO, we can obtain more stable structure of ligand 
molecule. This proposed technique can be used to provide a powerful tool for the chemist to 
evolve molecular structure of ligand once the functional protein is given. 
This work uses a two dimensional approach which has some limitations. A three dimensional 
approach using new data structure for the ligand will be our future research goal. Moreover, we 
have considered only inter-molecular forces but there are a number of intra-molecular forces 
like Bond stretching, angle binding, Dihedral angle. All these forces will give more accurate 
docking energy. 
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